Philip Morris International, Inc. (NYSE:PM) belongs to Consumer Goods sector. Its net profit margin is 31.40% and weekly performance is 2.71%. On last trading day company shares ended up $81.86. Philip Morris International, Inc. (NYSE:PM) distance from 50-day simple moving average (SMA50) is -0.71%. The Board of Directors of Philip Morris International, Inc. (NYSE:PM) declared a regular quarterly dividend of $1.00 per common share, payable on July 10, 2015, to shareholders of record as of June 25, 2015. The ex-dividend date is June 23, 2015.
On 12 June, DigitalGlobe, Inc. (NYSE:DGI) shares fell -1.09% and was closed at $29.86. DGI EPS growth in last 5 year was -29.90%. DigitalGlobe, Inc. (NYSE:DGI) year to date (YTD) performance is -3.58%. -DigitalGlobe (NYSE:DGI), announced that its management will be presenting at the Barclays High Yield Bond and Syndicated Loan Conference in Colorado Springs on Thursday, June 11, 2015 at 9:30 a.m. MT.
Motorola Solutions, Inc. (NYSE:MSI) ended the last trading day at $57.65. Company weekly volatility is calculated as 1.16% and price to cash ratio as 3.63. Motorola Solutions, Inc. (NYSE:MSI) showed a weekly performance of -1.06%. Announced June 10, that More than 1,000 U.S. employees at Motorola Solutions (NYSE:MSI) have signed letters urging Congress to pass the Bipartisan Congressional Trade Priorities and Accountability Act (TPA). The trade legislation, passed by the U.S. Senate last month and pending a vote in the U.S. House of Representatives, is critical for the growth of any global business. The legislation would establish concrete rules for international trade negotiations that would promote growth.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) belongs to Healthcare sector. Its weekly performance is 0.32%. On last trading day company shares ended up $3.15. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) distance from 50-day simple moving average (SMA50) is -5.17%. A 10-employee Norwood biotech has received the first of what it expects will be three orphan drug designations from the Food and Drug Administration for a drug it bought last year from a professor at UMass Medical Center in Worcester. Corbus Pharmaceuticals (NASDAQ:CRBP), which just started trading on the Nasdaq exchange in April, has been known among investors mostly for its plan to develop the drug to treat inflammation associated with cystic fibrosis which could potentially be used in conjunction with the suite of drugs being produced at Boston-based Vertex Pharmaceuticals (Nasdaq: VRTX).
BlackRock, Inc. (NYSE:BLK) shares fell -0.95% in last trading session and ended the day at $353.43. BLK Gross Margin is 89.30% and its return on assets is 1.40%. BlackRock, Inc. (NYSE:BLK) quarterly performance is -3.30%. BlackRock, Inc. (NYSE:BLK), agreed to buy Infraestructura Institucional, a Mexican infrastructure investment firm, to expand its presence in the country. Terms of the deal weren’t provided. Infraestructura Institucional oversees about $1 billion of invested and committed capital, New York-based BlackRock said Friday in a statement. The purchase will bring assets in BlackRock’s global infrastructure platform to more than $7 billion.